Last reviewed · How we verify
NCT04996849
Contemporary Characteristics of Penile Cancer
trial testing Data Capture in Penile Carcinoma in 499 participants. Terminated before completion.
17 September 2025
Quick facts
| Lead sponsor | M.D. Anderson Cancer Center |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 499 |
| Start date | 22 April 2004 |
| Primary completion | 17 September 2025 |
| Estimated completion | 17 September 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Data Capture
- Questionnaire Administration
Conditions studied
- Penile Carcinoma — all drugs for Penile Carcinoma →
- Squamous Cell Carcinoma of the Penis — all drugs for Squamous Cell Carcinoma of the Penis →
Sponsor
M.D. Anderson Cancer Center — full company profile →
Who can join
Eligibility, male only, with Penile Carcinoma or Squamous Cell Carcinoma of the Penis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study develops a prospective database of patients who are evaluated and treated for penile cancer. This will facilitate analyzing trends in cancer incidence, risk factors, treatment, complications, and tumor progression. It will also prospectively validate the importance of pathological prognostic factors previously reported and outcome related to contemporary treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04996849
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Data Capture
Trials testing the same drug.
- NCT04888338 — Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies · recruiting
- NCT03638479 — Utilizing Smart Devices to Identify New Phenotypical Characteristics in Movement Disorders · completed
Other recruiting trials for Penile Carcinoma
Currently open trials in the same condition.
- NCT07118176 — Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · Phase 1 · recruiting
- NCT05999396 — FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer · Phase 1 · recruiting
- NCT02496208 — Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · Phase 1 · active not recruiting
Other M.D. Anderson Cancer Center trials
Trials by the same sponsor.
- NCT07053020 — A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukem · Phase 1, PHASE2 · not yet recruiting
- NCT07052994 — A Phase Ia/Ib Trial of Revumenib Combined With Cytarabine, Daunorubicin, and Gemtuzumab Ozogamicin (GO) in Frontline and · Phase 1 · not yet recruiting
- NCT07137481 — Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Che · Phase 2 · not yet recruiting
- NCT07162480 — Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R/M) Aggressive Adenoid Cystic Ca · Phase 2 · not yet recruiting
- NCT07076498 — Engineered HSV-1 M032 for the Treatment of Children and Adults With Newly Diagnosed Diffuse Midline Glioma After Standar · Phase 1 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04996849 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by M.D. Anderson Cancer Center
- Last refreshed: 24 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04996849.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing